Report: Beyond Gatekeeping Primary Care Report

 

Effective Primary Care Support in the Management of Psoriasis & Psoriatic Arthritis

If the global community is to realize its commitments to universal health coverage (UHC) and to health and well-being for all, health systems will need to embrace new models of care delivery for diagnosing, treating, and managing people living with chronic conditions. Psoriasis and psoriatic arthritis are representative of many chronic diseases in that they require long-term care, access and adherence to treatment, psychosocial support, and coordination across multidisciplinary care providers. A primary care-coordinated approach to psoriasis and psoriatic arthritis management—wherein a specialist leads on disease treatment approaches, but a primary care provider ensures adequate consideration and management of co-morbidities and facilitates linkages to social support—could serve as an instructive benchmark and point of reference in the development of similar care models for managing other chronic non-communicable diseases.

White Paper: Shared Opportunities
for Action

Addressing NCDs: Psoriasis and its Co-Morbidities

People with psoriasis are at greater risk of developing co-morbid conditions. What is notable about psoriasis co-morbidities is that all are NCDs. Psoriasis also shares the same risk factors - tobacco use, unhealthy diet, physical inactivity, and harmful use of alcohol – as other NCDs. Diabetes and cardiovascular diseases are among the most severe psoriasis co-morbidities. At the same time, diabetes and cardiovascular diseases are two out of the four ‘main NCDs’ listed in the Global Action Plan for the Prevention and Control of NCDs (2013-2020), together with cancer and chronic respiratory diseases. Due to the risk of co-morbidities, it is essential that psoriasis is addressed early, closely, holistically and efficiently.

 

White Paper: Psoriasis and Universal Health Coverage

Psoriasis and Universal Health Coverage

Universal Health Coverage (UHC) is a crucial element to ensure people's access to quality health services without the risk of incurring financial hardship. It is a commitment that the UN Member States made as part of the Sustainable Development agenda.

UHC plays a fundamental role in ensuring quality psoriasis and psoriatic arthritis care at multiple levels. A strong primary healthcare system would ensure early diagnosis, access to a health care provider or specialist and prompt treatment. Moreover, the chronic nature of the disease implies that people living with psoriasis and psoriatic arthritis are subjected to life-long treatment regimens and experience a high share of out-of-pocket expenses. The achievement of UHC will reduce the burden of the disease for people living with psoriasis and will allow multiple economical and societal benefits.

 

Report: Psoriasis is a Serious Disease Deserving Global Attention

The Impacts of Psoriatic Disease and a Global Call to Action

The report seeks to inform the United Nations and other international organizations, Governments, Ministers of Health, donor countries and global philanthropic institutions, civil society, insurers/payers, health workers and psoriasis patients and their families that psoriasis is a serious inflammatory, noncommunicable autoimmune disease which carries severe physical, mental and socioeconomic burdens on over 125 million people worldwide.